TABLE 1.
Current hypothesis on pathogenesis of Q fever from clinical and experimental data
| Pathogenesis factor | Data in humans and experimental animals | Reference(s) |
|---|---|---|
| Acute Q fever (factors influencing clinical manifestations) | ||
| Host factors | Unknown | |
| C. burnetii strain | Unknown | |
| Route of infection | Aerosol versus intraperitoneal inoculation in BALB/c mouse and guinea pig models | 183, 219 |
| Inoculum dose | Myocarditis in guinea pigs | 183 |
| Chronic Q fever (factors influencing evolution to chronic Q fever) | ||
| Host factors | ||
| Immunosuppression | Patients with acquired immunosuppression (cancers, lymphomas, or HIV infection) | 138, 286, 294, 295 |
| Persistent infection in athymic mice | 170 | |
| Reactivation of infection with steroids or whole-body irradiation in mice and guinea pigs | 330, 331 | |
| Endocarditis in mice receiving cyclophosphamide | 17 | |
| Valvulopathy | Human endocarditis and previous valvulopathy | 286, 290 |
| Endocarditis in guinea pigs with damaged cardiac valves | 181 | |
| Pregnancy | Endocarditis in pregnant mice | 351 |
| Chronic Q fever in pregnant mammals and women | 20, 350 | |
| C. burnetii strain | Genetic heterogeneity among “acute” and “chronic” strains but lack of pathotype-specific gene in human strains | 314, 348 |
| Experimental endocarditis with Nine Mile “acute” strain | 17, 181, 239, 351 |